Biopharmaceutical Growth

JUPITER, Florida | January 29, 2026 — Myosin Therapeutics, a clinical-stage biotechnology company focused on first-in-class oncology therapies, has...

Frankfurt, Germany – January 30, 2026 — Merz Therapeutics has announced the appointment of Dan Staner as President, Region...